← All organizations
Highest phase reached
Phase 4
First clinical trial
Feb 1, 2008Last known activity
Jul 18, 2025
Timeline
1990s
- Jan 1, 1997
Singapore Eye Research Institute— Founded
Drugs by trial phase (21 distinct, 14 trials)
Phase 4 (4 own, 0 via acquisition)
Phase 3 (12 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Recent trials (22)
- NCT07249216Sponsor investigatorN/AJul 18, 2025
- NCT06731582Lead sponsorPhase 3Mar 12, 2024
- NCT06048380Lead sponsorPhase 3Oct 31, 2023
- NCT06048380Overall official - principal investigatorPhase 3Oct 31, 2023
- NCT06048380Reponsible party - principal investigatorPhase 3Oct 31, 2023
- NCT05137184Overall official - principal investigatorPhase 3Nov 12, 2021
- NCT04342156CollaboratorPhase 3Apr 30, 2020
- NCT04636918Overall official - principal investigatorPhase 4Nov 28, 2019
- NCT04636918Reponsible party - principal investigatorPhase 4Nov 28, 2019
- NCT04636918Lead sponsorPhase 4Nov 28, 2019
- NCT02943057Study chairPhase 4Aug 1, 2016
- NCT03932305Reponsible party - principal investigatorN/ANov 24, 2015
- NCT02638376Lead sponsorPhase 3Mar 1, 2013
- NCT02638376Overall official - principal investigatorPhase 3Mar 1, 2013
- NCT02638376Reponsible party - principal investigatorPhase 3Mar 1, 2013
Details
- Founded
- Singapore, SG Jan 1, 1997
- Last known activity
- Jul 18, 2025